Area of research
Psychiatry and Mental health · Philosophy
Research interest
Research interests include Schizophrenia research and treatment, Mental Health and Psychiatry, Tryptophan and brain disorders, and Mental Health Research Topics.
Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speed
Brain‐age prediction: Systematic evaluation of site effects, and sample age range and size
Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra‐high risk in the <scp>UHR</scp> 1000+ cohort
Higher emotion regulation flexibility predicts more stable negative emotions and faster affective recovery in early psychosis: an experience sampling study
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis
Serum immune markers and transition to psychosis in individuals at clinical high risk
Short- and long-term changes in symptom dimensions among patients with schizophrenia spectrum disorders and different durations of illness: A meta-analysis
Personal recovery suits us all: A study in patients with non-affective psychosis, unaffected siblings and healthy controls
fMRI connectivity as a biomarker of antipsychotic treatment response: A systematic review
A Cross-sectional Conceptual Replication and Longitudinal Evaluation of the PANSS-Autism-Severity-Score Measure Suggests it Does Not Capture Autistic Traits in Individuals With Psychosis
Efficacy of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Results from the Multi-Center INTERACT Randomized Controlled Trial
Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders
Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia
Autistic traits and alcohol use in adolescents within the general population
Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years
Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis
Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis
Individualized prediction of three- and six-year outcomes of psychosis in a longitudinal multicenter study: a machine learning approach
The Community Assessment of Psychic Experiences: Optimal cut‐off scores for detecting individuals with a psychotic disorder
Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis
Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling Study
Greater male than female variability in regional brain structure across the lifespan
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence
Dysregulated Lipid Metabolism Precedes Onset of Psychosis
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial
Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis
Cortical Thickness Trajectories across the Lifespan: Data from 17,075 healthy individuals aged 3-90 years